
The very lives of patients with AIDS, cancer, and other serious chronic diseases often hinge on intravenously administered medication. Unfortunately, an array of problems - from fragile veins to the complications of prolonged IV use - can make long-term intravenous treatment impossible. In 1989, John G. Kuhn developed a device that could meet the critical needs of these patients by providing an alternative method of infusing fluids into the bloodstream.
Kuhn is quick to point out that his graduate education at the university was vital to all that he has accomplished. Looking back at graduate school, Kuhn cites as invaluable the quality of the faculty, the caliber of his peers, and the level of resources available to him as a graduate student at the university. "Having resources at one's hands allows for more efficient growth and, thus, the ability to achieve."
Kuhn also appreciates the reputation that The University of Texas (UT) bestows upon its graduates: "When one graduates from a UT System school, it means something. I entered the job arena with an advantage over graduates from other schools."
It was this reputation that first provided Kuhn the opportunity to work outside of the state: "When I graduated from UT, I was accepted without question for an academic position at a college of pharmacy in another state." In the end, however, Kuhn wanted to return to his alma mater. "When I was ready to move my family back to Texas, my graduate education continued to provide me with a competitive edge."
Kuhn currently holds an endowed professorship with The University of Texas College of Pharmacy in Austin as well as The University of Texas Health Science Center at San Antonio.